

Josh Wolfe Discusses Innovative Investments (Podcast)
Aug 16, 2019
Josh Wolfe, co-founder of Lux Capital and a venture capital innovator, delves into the intersection of science and investment. He shares his journey from molecular biology to venture capital, offering insights into the importance of skepticism in evaluating startups, particularly in light of the Theranos case. Wolfe discusses the evolution of 3D printing, exploring its ethical implications and revolutionary applications. The conversation also highlights the transformative potential of technologies like CRISPR and the impact of GPUs in AI and defense, all while emphasizing the importance of diverse perspectives in investment.
AI Snips
Chapters
Books
Transcript
Episode notes
Hungry Entrepreneurs
- The best entrepreneurs often come from challenging backgrounds.
- This "chip on their shoulder" can fuel ambition and a hunger for success.
A Lucky Break
- Josh Wolfe's firm Lux Capital received early funding from Bill Conway, co-founder of The Carlyle Group.
- This lucky meeting, which Wolfe attributes to randomness and optionality, was pivotal for Lux's success.
Science Fiction's Influence on Tech
- Many technologies are inspired by science fiction, originating as fictional concepts before becoming reality.
- Venture capital involves believing in a vision before others understand, bridging the gap between fiction and fact.